SCCA Clinical Trials: Columbia Basin Hematology & Oncology
The affiliation between SCCA and Columbia Basin Hematology Oncology means patients living in southeastern Washington have access to the latest cancer treatment options, including those only available in clinical trials or at a comprehensive academic cancer center, such as SCCA.
Below is the first of many SCCA trials that's now being offerred for patients at Columbia Basin Hematology Oncology. If you have any questions about this or other upcoming trials, please contact Columbia Basin Hematology & Oncology:
Breast Cancer (New Diagnosed/Recurrent/Metastatic)
- Triple Negative Gen (6628)
Combined Targeted Therapies for Triple Negative Advanced Breast Cancer - A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib